Despite blowout earnings and hidden concerns about U.S. surgical volumes, JPMorgan maintains an "Overweight" rating on Intuitive Surgical (ISRG.US) and raises its price target to $475.

Zhitong Finance APP News: Global surgical robotics leader Intuitive Surgical (ISRG.US) released its Q3 2026 earnings report on October 20, US Eastern Time. JPMorgan released a research report the same day, maintaining its "Overweight" rating on the stock and raising the target price to $475. The bank said that within the high-growth soft-tissue robotics track, where penetration remains low, Intuitive Surgical is the most favorably positioned company. Data showed that the company's revenue, profit, and gross margin all significantly beat market expectations across the board, but the core metric of US procedure volume only met consensus expectations and failed to reach the optimistic expectations of buy-side institutions. After the earnings report was released, the stock came under pressure in after-hours trading.